P526 - Evaluating the Acceptance of a Continuous Blood Glucose Monitor for People with Insulin-Requiring Diabetes

Continuous Glucose Monitoring represents a significant advancement in diabetes management, yet there are still opportunities to improve the everyday user experience. This poster highlights the results of an online survey conducted with 757 respondents with type 1 and type 2 diabetes using a variety of insulin regimens to assess the acceptance of a new Continuous Blood Glucose Monitoring System (CBGM), that is inserted into the subclavian artery by a healthcare provider, lasts 2 years, and requires no on-body wearable components and one calibration session at the beginning of the wear. Overall, the findings indicate a positive sentiment toward the CBGM among a significant portion of the potential users.